UCHL1 and cancer: In addition, the list of confirmed compounds was enriched for AKT inhibitors (GSK2110183, GDC-0068, AZD5363), indicating that survival of UCHL1-related cancer cells depends at least in part on PI3K/AKT pathway activity, which appears to be lower as compared to other cancer cells (Supplementary Figure S7A).